Patent · US Active

Ocular device and method for glaucoma treatment

US11446179B2 · kind B2 · utility

1Cited by
27References
34Claims
0Family size

Inventor

Key dates

Filing dateApr 3, 2019
Grant dateSep 20, 2022
Priority date
Expiry dateJun 5, 2041

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61M2210/0612
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

An ocular device for treating glaucoma in an eye are described herein. The ocular device includes a first end, a second end, and a body. The first end is configured to seat in an anterior chamber of an eye. The first end includes an inlet configured to facilitate an ingress of aqueous humor into the ocular device. The second end is configured to seat in a tear film of the eye. The second end includes an outlet configured to facilitate release a flow of the aqueous humor into the tear film. The body is defined by a fluid conduit. The body includes a lumen having a lumen length and a lumen cross sectional area. The lumen length and the lumen cross sectional area are configured to control an intraocular pressure (IOP) of the eye by controlling the flow of the aqueous humor through the lumen.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.